Unmet Need for Reliable Immunological Detection Method for Anti-von Willebrand Factor Autoantibodies

Tsukasa Osaki; Masayoshi Souri; Chikako Yokoyama; Yasuo Magari; Akitada Ichinose

doi:10.1055/a-2002-2394

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2023; 123(04): 478-481
DOI: 10.1055/a-2002-2394

Letter to the Editor

Unmet Need for Reliable Immunological Detection Method for Anti-von Willebrand Factor Autoantibodies

Authors

Tsukasa Osaki

¹Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Iida-Nishi, Yamagata, Japan

²The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Yamagata, Japan

³Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science, Iida-Nishi, Yamagata, Japan
Masayoshi Souri

¹Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Iida-Nishi, Yamagata, Japan

²The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Yamagata, Japan

³Department of Public Health and Hygiene, Yamagata University Graduate School of Medical Science, Iida-Nishi, Yamagata, Japan
Chikako Yokoyama

²The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Yamagata, Japan

⁴Department of Biochemical Engineering, Graduate School of Science and Engineering, Yamagata University, Yonezawa, Japan

⁵Department of Chemistry and Bioengineering, Graduate School of Engineering, Osaka Metropolitan University, Osaka, Japan
Yasuo Magari

⁶Q-may Laboratory Corporation, Oita, Japan
Akitada Ichinose

¹Department of Molecular Patho-Biochemistry and Patho-Biology, Yamagata University School of Medicine, Iida-Nishi, Yamagata, Japan

²The Japanese Collaborative Research Group (JCRG) on Autoimmune Acquired Coagulation Factor Deficiencies supported by the Japanese Ministry of Health, Labor and Welfare (MHLW), Yamagata, Japan

Abstract

Full Text

References

References
1 Cugno M, Gualtierotti R, Tedeschi A, Meroni PL. Autoantibodies to coagulation factors: from pathophysiology to diagnosis and therapy. Autoimmun Rev 2014; 13 (01) 40-48 Erratum in: Autoimmun Rev. 2015 Jul;14(7):650
2 Ichinose A. Immune-mediated acquired coagulation factor deficiencies: state-of-the-art in diagnosis and management [in Japanese]. Rinsho Ketsueki 2019; 60 (06) 667-679
3 Ahmed AE. Autoantibodies to coagulation factors and bleeding disorders. Clin Rev Allergy Immunol 1998; 16 (03) 313-319
4 Macik BG, Crow P. Acquired autoantibodies to coagulation factors. Curr Opin Hematol 1999; 6 (05) 323-328
5 Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001; 5 (04) 389-404 , quiz 431
6 Ichinose A. Japanese Collaborative Research Group on AH13. Autoimmune acquired factor XIII deficiency due to anti-factor XIII/13 antibodies: a summary of 93 patients. Blood Rev 2017; 31 (01) 37-45
7 Osaki T, Souri M, Ichinose A. Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development. Int J Hematol 2022; 115 (05) 672-685
8 Osaki T, Souri M, Ichinose A. Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis. PLoS One 2021; 16 (09) e0257322
9 Ogawa Y, Yanagisawa K, Uchiumi H. et al. Clinical characteristics and outcomes of acquired hemophilia A: experience at a single center in Japan. Int J Hematol 2017; 106 (01) 82-89
10 Ichinose A, Osaki T, Souri M. Autoimmune acquired factor XIII deficiency in Japan 2021 update: focused on annual incidence and clinical features. Haemophilia 2022; 28 (05) e121-e124
11 Ichinose A, Osaki T, Souri M. A review of coagulation abnormalities of autoimmune acquired factor V deficiency with a focus on Japan. Semin Thromb Hemost 2022; 48 (02) 206-218
12 Ichinose A, Osaki T, Souri M, Favaloro EJ. A review of autoimmune acquired von Willebrand factor deficiency in Japan. Semin Thromb Hemost 2022; 48 (08) 911-925
13 Tiede A, Priesack J, Werwitzke S. et al. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 2008; 6 (04) 569-576
14 Mohri H, Motomura S, Kanamori H. et al. Clinical significance of inhibitors in acquired von Willebrand syndrome. Blood 1998; 91 (10) 3623-3629 Erratum in: Blood 1999;93(1):413
15 Siaka C, Rugeri L, Caron C, Goudemand J. A new ELISA assay for diagnosis of acquired von Willebrand syndrome. Haemophilia 2003; 9 (03) 303-308
16 Franchi F, Biguzzi E, Stufano F, Siboni SM, Baronciani L, Peyvandi F. A two-step approach (enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with acquired von Willebrand syndrome. Thromb Res 2014; 134 (06) 1316-1322
17 Dicke C, Holstein K, Schneppenheim S. et al. Acquired hemophilia A and von Willebrand syndrome in a patient with late-onset systemic lupus erythematosus. Exp Hematol Oncol 2014; 3: 21
18 Dicke C, Schneppenheim S, Holstein K. et al. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias. Ann Hematol 2016; 95 (06) 945-957
19 Ichinose A, Kohler HP, Philippou H. Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Recommendation for ISTH/SSC Criterion 2015 for autoimmune acquired factor XIII/13 deficiency. Thromb Haemost 2016; 116 (04) 772-774
20 Ihara A, Suzuki N, Matsushita T, Ichinose A. Acquired von Willebrand syndrome in a patient with immune thrombocytopenic purpura [in Japanese]. Rinsho Ketsueki 2015; 56 (07) 901-904
21 Kobayashi N, Ogawa Y, Yanagisawa K. et al. Acquired immune-mediated von Willebrand syndrome accompanied by antiphospholipid syndrome [in Japanese]. Rinsho Ketsueki 2017; 58 (06) 613-618
22 Yokoyama C, Ikeda S, Osaki T, Souri M, Ichinose A. Generation and application of rat monoclonal antibodies specific for a human blood coagulation protein: von Willebrand factor. Monoclon Antib Immunodiagn Immunother 2019; 38 (03) 133-136
23 Tiede A, Rand JH, Budde U, Ganser A, Federici AB. How I treat the acquired von Willebrand syndrome. Blood 2011; 117 (25) 6777-6785
24 James AH, Eikenboom J, Federici AB. State of the art: von Willebrand disease. Haemophilia 2016; 22 (Suppl 5): 54-59
25 Lee A, Sinclair G, Valentine K, James P, Poon MC. Acquired von Willebrand syndrome: von Willebrand factor propeptide to von Willebrand factor antigen ratio predicts remission status. Blood 2014; 124 (05) e1-e3

Supplementary Material

Supplementary Material (PDF)